Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker

Background: Isolation and characterization of tumourigenic colon cancer initiating cells may help to develop novel diagnostic and therapeutic procedures. Methods: We characterized a panel of fourteen human colon carcinoma cell lines and their corresponding xenografts for the surface expression of po...

Full description

Saved in:
Bibliographic Details
Main Authors: Schneider, Meike (Author) , Huber, Johannes (Author) , Hadaschik, Boris (Author)
Format: Article (Journal)
Language:English
Published: 2012
In: BMC cancer
Year: 2012, Volume: 12
ISSN:1471-2407
DOI:10.1186/1471-2407-12-96
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1471-2407-12-96
Verlag, kostenfrei, Volltext: https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-12-96
Get full text
Author Notes:Meike Schneider, Johannes Huber, Boris Hadaschik, Gabrielle M Siegers, Heinz-Herbert Fiebig and Julia Schüler

MARC

LEADER 00000caa a2200000 c 4500
001 1577040465
003 DE-627
005 20241009120816.0
007 cr uuu---uuuuu
008 180629s2012 xx |||||o 00| ||eng c
024 7 |a 10.1186/1471-2407-12-96  |2 doi 
035 |a (DE-627)1577040465 
035 |a (DE-576)507040465 
035 |a (DE-599)BSZ507040465 
035 |a (OCoLC)1341013119 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schneider, Meike  |e VerfasserIn  |0 (DE-588)1079049096  |0 (DE-627)840123760  |0 (DE-576)452174120  |4 aut 
245 1 0 |a Characterization of colon cancer cells  |b a functional approach characterizing CD133 as a potential stem cell marker  |c Meike Schneider, Johannes Huber, Boris Hadaschik, Gabrielle M Siegers, Heinz-Herbert Fiebig and Julia Schüler 
264 1 |c 2012 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published: 20 March 2012 
500 |a Gesehen am 29.06.2018 
520 |a Background: Isolation and characterization of tumourigenic colon cancer initiating cells may help to develop novel diagnostic and therapeutic procedures. Methods: We characterized a panel of fourteen human colon carcinoma cell lines and their corresponding xenografts for the surface expression of potential stem cell markers CD133, CD24, CD44, CDCP1 and CXCR4. In five cell lines and nine xenografts, mRNA expression of these markers was determined. Tumour growth behaviour of CD133+, CD133- and unsorted SW620 cells was evaluated in vivo. Results: All five putative stem cell markers showed distinct expression patterns in the tumours examined. Two patient-derived cell lines highly expressed CD133 (> 85% of positive cells) and three other cell lines had an expression level of about 50% whereas in long-term culture based models CD133 expression ranged only from 0 to 20%. In 8/14 cell lines, more than 80% of the cells were positive for CD24 and 11/14 were over 70% positive for CD44. 10/14 cell lines expressed CDCP1 on ≥ 83% of cells. CXCR4 expression was determined solely on 94 L and SW480., Analyses of the corresponding xenografts revealed a significant reduction of cell numbers expressing the investigated surface markers and showed single cell fractions expressing up to three markers simultaneously., Statistical analysis revealed that the CXCR4 mRNA level correlates negatively with the protein expression of CD133, CD44, CD24 and CDCP1 in cell lines and xenografts., A lower differentiation grade of donor material correlated with a higher CDCP1 mRNA expression level in the respective tumour model., In vivo growth behaviour studies of SW620 revealed significantly higher take rates and shorter doubling times in the tumour growth of CD133 positive subclones in comparison to the unsorted cell line or CD133 negative subclones. Conclusions: Our data revealed correlations in the expression of surface markers CD44 and CD24 as well as CD44 and CDCP1 and strongly suggest that CD133 is a stem cell marker within our colon carcinoma panel. Further studies will elucidate its role as a potential therapeutic target. 
700 1 |a Huber, Johannes  |d 1980-  |e VerfasserIn  |0 (DE-588)1066882967  |0 (DE-627)817999566  |0 (DE-576)426260554  |4 aut 
700 1 |a Hadaschik, Boris  |d 1974-  |e VerfasserIn  |0 (DE-588)124300553  |0 (DE-627)085770930  |0 (DE-576)294109013  |4 aut 
773 0 8 |i Enthalten in  |t BMC cancer  |d London : BioMed Central, 2001  |g 12(2012) Artikel-Nummer 96, 11 Seiten  |h Online-Ressource  |w (DE-627)326643710  |w (DE-600)2041352-X  |w (DE-576)107014645  |x 1471-2407  |7 nnas  |a Characterization of colon cancer cells a functional approach characterizing CD133 as a potential stem cell marker 
773 1 8 |g volume:12  |g year:2012  |a Characterization of colon cancer cells a functional approach characterizing CD133 as a potential stem cell marker 
856 4 0 |u http://dx.doi.org/10.1186/1471-2407-12-96  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-12-96  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180629 
993 |a Article 
994 |a 2012 
998 |g 124300553  |a Hadaschik, Boris  |m 124300553:Hadaschik, Boris  |d 910000  |d 910200  |e 910000PH124300553  |e 910200PH124300553  |k 0/910000/  |k 1/910000/910200/  |p 3 
998 |g 1066882967  |a Huber, Johannes  |m 1066882967:Huber, Johannes  |d 910000  |d 910200  |e 910000PH1066882967  |e 910200PH1066882967  |k 0/910000/  |k 1/910000/910200/  |p 2 
998 |g 1079049096  |a Schneider, Meike  |m 1079049096:Schneider, Meike  |p 1  |x j 
999 |a KXP-PPN1577040465  |e 3014769789 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"family":"Schneider","given":"Meike","role":"aut","display":"Schneider, Meike"},{"display":"Huber, Johannes","role":"aut","given":"Johannes","family":"Huber"},{"given":"Boris","role":"aut","display":"Hadaschik, Boris","family":"Hadaschik"}],"name":{"displayForm":["Meike Schneider, Johannes Huber, Boris Hadaschik, Gabrielle M Siegers, Heinz-Herbert Fiebig and Julia Schüler"]},"language":["eng"],"title":[{"title_sort":"Characterization of colon cancer cells","title":"Characterization of colon cancer cells","subtitle":"a functional approach characterizing CD133 as a potential stem cell marker"}],"note":["Published: 20 March 2012","Gesehen am 29.06.2018"],"relHost":[{"pubHistory":["1.2001 -"],"part":{"volume":"12","text":"12(2012) Artikel-Nummer 96, 11 Seiten","year":"2012"},"language":["eng"],"title":[{"title":"BMC cancer","title_sort":"BMC cancer"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"326643710","origin":[{"publisher":"BioMed Central ; Springer","dateIssuedDisp":"2001-","dateIssuedKey":"2001","publisherPlace":"London ; Berlin ; Heidelberg"}],"note":["Gesehen am 22.05.20"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1471-2407"],"zdb":["2041352-X"],"eki":["326643710"]},"disp":"Characterization of colon cancer cells a functional approach characterizing CD133 as a potential stem cell markerBMC cancer"}],"id":{"doi":["10.1186/1471-2407-12-96"],"eki":["1577040465"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1577040465","origin":[{"dateIssuedDisp":"2012","dateIssuedKey":"2012"}]} 
SRT |a SCHNEIDERMCHARACTERI2012